Riverview Trust Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-321
| Closed | -$9.01K | – | 197 |
|
|
2026
Q1 | $9.01K | Sell |
321
-1,193
| -79% | -$31.8K | 0.01% | 170 |
|
|
2025
Q4 | $37.7K | Sell |
1,514
-2,305
| -60% | -$58.1K | 0.05% | 133 |
|
|
2025
Q3 | $97.3K | Sell |
3,819
-300
| -7% | -$7.41K | 0.12% | 96 |
|
|
2025
Q2 | $99.8K | Sell |
4,119
-12,295
| -75% | -$287K | 0.12% | 88 |
|
|
2025
Q1 | $416K | Sell |
16,414
-5,326
| -24% | -$139K | 0.41% | 48 |
|
|
2024
Q4 | $577K | Sell |
21,740
-92
| -0.4% | -$2.5K | 0.52% | 36 |
|
|
2024
Q3 | $632K | Buy |
21,832
+91
| +0.4% | +$2.65K | 0.55% | 34 |
|
|
2024
Q2 | $608K | Buy |
21,741
+4,265
| +24% | +$117K | 0.58% | 33 |
|
|
2024
Q1 | $485K | Sell |
17,476
-3,787
| -18% | -$105K | 0.37% | 47 |
|
|
2023
Q4 | $612K | Buy |
21,263
+3,537
| +20% | +$107K | 0.62% | 40 |
|
|
2023
Q3 | $588K | Sell |
17,726
-122
| -0.7% | -$4.31K | 0.52% | 40 |
|
|
2023
Q2 | $655K | Sell |
17,848
-2,658
| -13% | -$103K | 0.59% | 33 |
|
|
2023
Q1 | $837K | Buy |
20,506
+463
| +2% | +$20K | 0.77% | 27 |
|
|
2022
Q4 | $1.03M | Sell |
20,043
-2,756
| -12% | -$132K | 0.97% | 22 |
|
|
2022
Q3 | $998K | Sell |
22,799
-119
| -0.5% | -$5.78K | 0.97% | 20 |
|
|
2022
Q2 | $1.2M | Buy |
22,918
+4,061
| +22% | +$207K | 1.05% | 19 |
|
|
2022
Q1 | $976K | Buy |
18,857
+3,665
| +24% | +$190K | 0.72% | 26 |
|
|
2021
Q4 | $897K | Hold |
15,192
| – | – | 0.53% | 28 |
|
|
2021
Q3 | $653K | Buy |
15,192
+250
| +2% | +$11.1K | 0.69% | 32 |
|
|
2021
Q2 | $585K | Hold |
14,942
| – | – | 0.62% | 33 |
|
|
2021
Q1 | $541K | Hold |
14,942
| – | – | 0.6% | 34 |
|
|
2020
Q4 | $550K | Sell |
14,942
-888
| -6% | -$32.6K | 0.61% | 33 |
|
|
2020
Q3 | $551K | Sell |
15,830
-264
| -2% | -$9.26K | 0.63% | 33 |
|
|
2020
Q2 | $499K | Hold |
16,094
| – | – | 0.48% | 40 |
|
|
2020
Q1 | $498K | Sell |
16,094
-7,460
| -32% | -$254K | 0.48% | 34 |
|
|
2019
Q4 | $876K | Sell |
23,554
-7
| -0% | -$249 | 0.59% | 32 |
|
|
2019
Q3 | $803K | Hold |
23,561
| – | – | 0.56% | 33 |
|
|
2019
Q2 | $968K | Sell |
23,561
-527
| -2% | -$20.9K | 0.68% | 25 |
|
|
2019
Q1 | $971K | Buy |
24,088
+88
| +0.4% | +$3.52K | 0.73% | 23 |
|
|
2018
Q4 | $994K | Buy |
+24,000
| New | +$996K | 0.78% | 22 |
|
Other funds holding PFE
Riverview Trust Company's PFE Position: Q2 2026 in Review
Riverview Trust Company sold out of Pfizer (PFE) in Q2 2026, closing a stake of 321 shares — an estimated $9.01K sold.
Riverview Trust Company first reported a position in PFE in Q4 2018 and held it in 30 quarters. The position peaked at $1.2M in Q2 2022. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Riverview Trust Company reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Riverview Trust Company sold 321 Pfizer shares in Q2 2026, an estimated $9.01K.
- Riverview Trust Company first reported a position in Pfizer in Q4 2018 and held it in 30 quarters.
- Riverview Trust Company's Pfizer position peaked at $1.2M in Q2 2022.
- 2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Riverview Trust Company's 13F filing for Q2 2026, filed 3 Aug 2026.